Challenge 100
100 days. 100 miles.
There's only one rule with this challenge: you must complete at least 100 miles in less than 100 days. How you complete it, is up to you!
We are Epilepsy Society. The UK's leading charity for epilepsy research and support.
Due to current circumstances in relation to the coronavirus some of our services have been reduced with our staff working from home. Despite this our top priority at Epilepsy Society is to support people living with epilepsy. You may notice a slight change in our communications. For the time being, we will focus our efforts on making sure you have all the information you need from us to help you as best we can in the current climate.
Leading care provider
Our range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Cutting edge research
Epilepsy Society's Chalfont Centre is unique in bringing together intellectual capital to form a powerhouse multidisciplinary team who contribute to a wide ranging spectrum of research.
Epilepsy Support
Our confidential epilepsy helpline and online information give help and support to people who are affected by epilepsy.
Advocacy
We are a voice for people with epilepsy, striving to push epilepsy up the political agenda and bring about change at government level.
Medical services
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
Care services
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Campaigns
Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online harm, and from medicines supply to public transport access, we raise awareness of the daily challenges facing people with epilepsy.
Latest news
Helping to shape the future of research
What matters most to you about epilepsy research? What are the outcomes that are most important to you? If you could sit down with a researcher, what would be the top three priorities that you would like to them to focus on in their epilepsy research?
Vimpat – no shortage but some delivery issues
We are aware that some people have experienced difficulties in accessing the following epilepsy medication: Vimpat 50mg and Vimpat liquid. The pharmaceutical company UCB has assured us that there are no supply issues, though there have been delivery issues in some areas resulting in local shortages.
Epilim Chrono modified release - some local issues
We are aware that some people have experienced difficulties in accessing the following epilepsy medication: Epilim Chrono modified release 200mg.
Are you thinking about a new career for the New Year?
The Epilepsy Society has great job prospects for anyone who would like a career supporting people with disabilities
Why comedian Jake Lambert wants the world to laugh about his epilepsy
Comedian Jake Lambert is 32 and on a mission to get people talking – and laughing – about epilepsy, more specifically his own epilepsy. He uses his stand-up comedy gigs across the country to bring the house down while at the same time helping audiences to understand more about the condition. And it’s working.
Zach's Law moves a step closer to protecting people with epilepsy online
In a landmark report, MPs and peers are urging the government to introduce a new offence – Zach’s Law – to protect people with epilepsy from malicious posts designed to cause seizures.
Our research
Research
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Therapeutic Drug Monitoring (TDM)
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
Genomics
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
You can call our helpline on 01494 601 400.
Our Helpline is open five days a week, Monday to Friday 9am to 4pm, (Wednesday 9am to 7.30pm).
You can also reach us by email
helpline@epilepsysociety.org.uk.